A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

High-Risk Prostate Cancer

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California, United States
Contact: Study coordinator (Matthew B Rettig, MD) · Matthew.rettig@va.gov · 310-478-3711
Contact: Study coordinator (Samantha M Tran) · Samantha.Tran@va.gov · 3104783711
James J. Peters VA Medical Center, Bronx, NY, The Bronx, New York, United States
Contact: Study coordinator (Izak Faiena, MD) · izak.faiena@va.gov
Contact: Study coordinator (Amelia Kiliveros) · amelia.kiliveros@va.gov
VA Portland Health Care System, Portland, OR, Portland, Oregon, United States
Contact: Study coordinator (Ryan P Kopp, MD) · ryan.kopp@va.gov · 503-220-8262
Contact: Study coordinator (Laura Onstad, RN) · laura.onstad@va.gov · (503) 721-1060
Contact: Principal Investigator (Ryan P Kopp, MD)
Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States
Contact: Study coordinator (Steven Savage, MD) · 843-789-7816
Contact: Study coordinator (Elina Bolukbasi, RN) · 8435775011
South Texas Health Care System, San Antonio, TX, San Antonio, Texas, United States
VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States
Contact: Study coordinator (Robert B Montgomery, MD) · rbmontgo@uw.edu · 206-277-6878
Contact: Study coordinator (Makayla L Dejong) · Makayla.Dejong@va.gov · 2062774527

מובילי המחקר

Ryan P Kopp, MD
Principal Investigator
VA Portland Health Care System, Portland, OR